kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports KRAS-targeted therapies in cancer: novel
KRAS targeted therapies in cancer: novel approaches and overcoming resistance BMJ Oncology Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv KRAS in Non Small Cell Lung Cancer Encyclopedia MDPI The KRAS G12D mutation induces metabolic vulnerability in B cell acute lymphoblastic leukemia ScienceDirect
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



